3SBio Inc  

(Public, NASDAQ:SSRX)   Watch this stock  
Find more results for SSRX
May 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 10.15 - 16.70
Open     -
Vol / Avg. 0.00/149,084.00
Mkt cap 366.10M
P/E 22.58
Div/yield     -
EPS 0.73
Shares     -
Beta 1.46
Inst. own     -

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 30.68% 25.80%
Operating margin 38.22% 34.55%
EBITD margin - 34.48%
Return on average assets - 16.32%
Return on average equity - 29.13%
Employees 1,461 -
CDP Score - -


No. 3 A1, Road 10 Shenyang Economy & Technology Development Zone
+86-24-25811820 (Phone)
+86-24-25811821 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


3SBio Inc. is a biotechnology company. The Company is focused on researching, developing, manufacturing and marketing biopharmaceutical products. The Company primarily focuses on product candidates in two core therapeutic areas, such as nephrology and oncology. The Company has three research and development platforms, including a mammalian cell-based platform, a bacterial cell-based platform and a chemical platform. Its core products include TPIAO and EPIAO. The Company's TPIAO is a commercialized recombinant human thrombopoietin (rhTPO) product used for the treatment of certain types of thrombocytopenia, a deficiency of platelets. The Company's EPIAO is an injectable recombinant human erythropoietin (rhEPO). The Company's other products include IV Iron Sucrose, Inleusin, Intefen, SEPO, Sparin, Metadoxine, Docetaxel, Anastrozole, Azasetron, Amikacin and Qiming Keli. The Company maintains operation facilities in Shenyang, Benxi, Hangzhou and Shenzhen, as well as in Como, Italy.

Officers and directors

Jing Lou Chairman of the Board, Chief Executive Officer
Age: 49
Bo Tan Chief Financial Officer, Principal Financial and Accounting Officer
Age: 40
Bin Huang Vice President - Human Resources, Director
Age: 51
Ke Li Vice President, Corporate Secretary
Age: 44
Dongmei Su Vice President - Research & Development, Chief Technology Officer, Director
Age: 42
Peiguo Cong Independent Director
Age: 58
Tianruo Pu Independent Director
Age: 46
Moujia Qi Independent Director
Age: 79
Mingde Yu Independent Director
Age: 66